RecruitMe Clinical Trial

CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplant for Malignant Disease
CD34 Stem Cell Selection for Malignant Condition
Sponsor:Investigator initiated study
Enrolling:Male and Female Patients
Maximum Age:22 years old
IRB Number:AAAK8060
U.S. Government ID:NCT02061800
Contact: Brian Volonte: (212) 304-7806 / bv2272@cumc.columbia.edu
Additional Study Information:

The purpose of this study is to determine the incidence and severity of acute GVHD following CD34+ selection in children, adolescents and young adults receiving an allogeneic peripheral blood stem cell transplant from a family member or unrelated adult donor for a malignant condition.

Do You Qualify?
Are you less than 22 years of age?YesNo
Do you have a malignant disorder such as CML, AML, MDS, JMML, ALL or lymphoma?YesNo
Submit
Cancel
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Brian Volonte
Email: bv2272@cumc.columbia.edu
Phone: (212) 304-7806